CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 148 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,360,946 | +33.2% | 560,761 | -2.2% | 0.00% | +100.0% |
| Q2 2023 | $6,275,937 | -6.9% | 573,145 | -25.9% | 0.00% | 0.0% |
| Q1 2023 | $6,743,577 | +1162.2% | 773,346 | +807.5% | 0.00% | – |
| Q4 2022 | $534,292 | -35.0% | 85,214 | -63.7% | 0.00% | – |
| Q3 2022 | $822,000 | +9.2% | 234,722 | -8.0% | 0.00% | – |
| Q2 2022 | $753,000 | -57.1% | 255,043 | -54.8% | 0.00% | – |
| Q1 2022 | $1,754,000 | -10.1% | 564,116 | -2.3% | 0.00% | – |
| Q4 2021 | $1,952,000 | +82.4% | 577,120 | +97.0% | 0.00% | – |
| Q3 2021 | $1,070,000 | +72.3% | 292,964 | +105.8% | 0.00% | – |
| Q2 2021 | $621,000 | +47.5% | 142,363 | +53.5% | 0.00% | – |
| Q1 2021 | $421,000 | -92.2% | 92,768 | -90.1% | 0.00% | -100.0% |
| Q4 2020 | $5,401,000 | +642.9% | 940,982 | +835.6% | 0.00% | – |
| Q3 2020 | $727,000 | -71.3% | 100,578 | -86.1% | 0.00% | -100.0% |
| Q2 2020 | $2,531,000 | +136.5% | 724,975 | +0.3% | 0.00% | – |
| Q1 2020 | $1,070,000 | +43.4% | 722,501 | +89.9% | 0.00% | – |
| Q4 2019 | $746,000 | -43.7% | 380,401 | +46.9% | 0.00% | – |
| Q3 2019 | $1,326,000 | +31.7% | 259,030 | +84.0% | 0.00% | – |
| Q2 2019 | $1,007,000 | -63.8% | 140,752 | -32.8% | 0.00% | -100.0% |
| Q1 2019 | $2,782,000 | +273.9% | 209,495 | +121.6% | 0.00% | – |
| Q4 2018 | $744,000 | +2.5% | 94,549 | +44.3% | 0.00% | – |
| Q3 2018 | $726,000 | -10.3% | 65,508 | +8.6% | 0.00% | – |
| Q2 2018 | $809,000 | -85.9% | 60,297 | -86.4% | 0.00% | -100.0% |
| Q1 2018 | $5,746,000 | +2816.8% | 442,343 | +1966.3% | 0.00% | – |
| Q4 2017 | $197,000 | +515.6% | 21,407 | +29.3% | 0.00% | – |
| Q3 2016 | $32,000 | -92.3% | 16,554 | -61.1% | 0.00% | – |
| Q4 2014 | $418,000 | – | 42,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
| Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
| TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
| COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
| Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
| Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
| Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
| Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |